IPX IperionX
IperionX earnings company data as of 10:00 AM ET 10/10
Scheduled
1 period, newest first, nothing reported yet. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q2 | 29 Sep | EPS | -0.55 | — | — |
| Rev | — | — | — |
Insider trades
Open-market buys and sales by IPX's executives, directors and 10% owners in the last 12 months, from their Form 4s
- $7.8M bought by 4 insiders
- None no sales outside a trading plan
- None no planned (10b5-1) sales
-
Anastasios Arima CEOBuy$497K 138,720 shares at $3.58 +1.1% to stakeTraded Jul 10 Filed Jul 13
-
Todd Hannigan ChairBuy$1.9M 525,000 shares at $3.58 +2% to stakeTraded Jul 10–13 Filed Jul 13
-
Anastasios Arima CEOBuy$494K 110,000 shares at $4.49 +0.9% to stakeTraded Apr 28 Filed Apr 30
-
Todd Hannigan ChairBuy$2.1M 480,000 shares at $4.33 +1.9% to stakeTraded Apr 28–29 Filed Apr 29
-
Anastasios Arima CEOBuy$1.8M 479,800 shares at $3.74Traded Mar 27 Filed Mar 30
-
Todd Hannigan DirectorBuy$721K 225,225 shares at $3.20 +0.9% to stakeTraded Mar 27 Filed Mar 30
-
Toby Edgcumbe Symonds PresidentBuy$263K 11,000 shares at $23.87 New stakeTraded Mar 27 Filed Mar 30
-
R Tony Tripeny DirectorBuy$99K 4,187 shares at $23.76 New stakeTraded Mar 27 Filed Mar 30
Also filed in the last 12 months, not counted as buying or selling: 1 stock grant and 1 option exercise.
SEC filings
Recent issuer filings from EDGAR, 21 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| 6-K | Filing Doc | ||
| 20-F | Filing Doc | ||
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| 424B5 | Filing Doc | ||
| 6-K | Filing Doc | ||
| 424B5 | Filing Doc | ||
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| 6-K/A | Filing Doc | ||
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| 6-K | Filing Doc |
No filings match this filter.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.